Marion Merrell Dow
Executive Summary
Expanding German presence with proposal to acquire Henning Berlin GmbH for undisclosed terms, MMD announces Nov. 26. Henning's 1991 sales are projected at $ 70 mil. and Merrell Dow Pharma's at $ 55 mil. The acquisition will add 450 associates, including a field force of about 100, to Merrell Dow's German 200 employees, which include 135 field sales personnel. Henning's key products are a line for thyroid disorders and related diagnostic tests, including Carbimazole Henning for hyperthyroidism and L- Thyroxin for hypothyroidism. . . .